Loading
A small Indian study measuring how often the PanTum Detect blood test is positive in people with and without cancer.
PanTum Detect diagnostic accuracy study (NCT06456216) is an observational study sponsored by Max Healthcare Insititute Limited. It evaluated the sensitivity and specificity of PanTum Detect for solid tumours in a known cancer population and a cancer-free population.
The registry record, read on 29 October 2026, gives its status as completed, with 90 participants enrolled, a start on 21 February 2022 and primary completion on 14 November 2022.
Shares Zyagnum, PanTum Detect, Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/